Literature DB >> 15363984

Neuroprotective and neurotoxic effects of cyclosporine A on transient focal ischemia in mdr1a knockout mice.

Michihiro Murozono1, Shohei Matsumoto, Eriko Matsumoto, Atsushi Isshiki, Yasuo Watanabe.   

Abstract

The proper dose of cyclosporine A as a neuroprotective agent was investigated using the middle cerebral artery occlusion model of mdr1a knockout mice. After a 30-min occlusion period, reperfusion was performed and the vehicle or cyclosporine A (1 mg/kg or 10 mg/kg x 2) was intraperitoneally administered to each animal model group. Forty eight hours after reperfusion, infarction volume in the 1 mg/kg cyclosporine A group was significantly less than that seen in the vehicle group, although, in the high dose cyclosporine A group, infarction volumes were significantly higher than those seen in the vehicle group. These results demonstrate that cyclosporine A shows not only anti-ischemic effects, but also neurotoxic effects depending on the dosage penetrating into the brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363984     DOI: 10.1016/j.ejphar.2004.06.068

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Calcineurin and Erk1/2-signaling pathways are involved in the antiapoptotic effect of cyclosporin A on astrocytes exposed to simulated ischemia in vitro.

Authors:  Bozena Gabryel; Anna Pudelko; Jakub Adamczyk; Ireneusz Fischer; Andrzej Malecki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-10-05       Impact factor: 3.000

3.  Prevention of Cyclophilin D-Mediated mPTP Opening Using Cyclosporine-A Alleviates the Elevation of Necroptosis, Autophagy and Apoptosis-Related Markers Following Global Cerebral Ischemia-Reperfusion.

Authors:  Farinoosh Fakharnia; Fariba Khodagholi; Leila Dargahi; Abolhassan Ahmadiani
Journal:  J Mol Neurosci       Date:  2016-09-23       Impact factor: 3.444

4.  Reduction of brain infarction induced by a transient brain ischemia in mdr1a knockout mice.

Authors:  Michihiro Murozono; Shohei Matsumoto; Shinya Okada; Daisuke Nagaoka; Atsushi Isshiki; Yasuo Watanabe
Journal:  Neurochem Res       Date:  2009-03-10       Impact factor: 3.996

5.  Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains.

Authors:  Austin C Boese; Auston Eckert; Milton H Hamblin; Jean-Pyo Lee
Journal:  Exp Neurol       Date:  2020-03-05       Impact factor: 5.330

6.  Cyclosporine A Plus Ischemic Postconditioning Improves Neurological Function in Rats After Cardiac Resuscitation.

Authors:  Xiang Zhou; YanLiang Qu; GuoShen Gan; ShuiBo Zhu; Yang Huang; Yong Liu; Jian Zhu; Biao Xie; ZhiTian Tan
Journal:  Neurocrit Care       Date:  2020-06       Impact factor: 3.210

Review 7.  Edaravone and cyclosporine A as neuroprotective agents for acute ischemic stroke.

Authors:  Shohei Matsumoto; Michihiro Murozono; Masahiro Kanazawa; Takeshi Nara; Takuro Ozawa; Yasuo Watanabe
Journal:  Acute Med Surg       Date:  2018-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.